Home > Healthcare > Pharmaceuticals > Finished Drug Form > Botulinum Toxin Market
Botulinum Toxin Market Share
- Report ID: GMI3408
- Published Date: May 2022
- Report Format: PDF
Botulinum Toxin Market Share
Major players operating in the botulinum toxin industry include:
- AbbVie Inc
- Merz Pharma
- Eisai Co Ltd
- Hugel Inc
- Medytox Inc
- Ipsen Revance Therapeutics
These players opt for various inorganic growth strategies such as partnerships, collaborations, mergers and acquisitions, and product launch initiatives to create a global footprint and industry competition.
Frequently Asked Questions (FAQ) :
Botulinum toxin market is slated to surpass USD 11.5 billion by 2030 and is expected to expand at a rate of 6.9% from 2022 to 2030 considering the rising demand for minimally invasive or non-invasive surgeries in cosmetology and the growing product application in cosmetic surgeries.
The market value from the aesthetic application is anticipated to depict a CAGR of 6.2% through 2030 owing to the rising concern for aesthetic appearance in developing and developed regions.
North America botulinum toxin market is estimated to exceed USD 8.3 billion by 2030 considering the growing number of cosmetic procedures and an increase in disposable income.
Prominent companies in the botulinum toxin market comprise Hugel Inc., Merz Pharma, Revance Therapeutics, Inc., Eisai Co., Ltd., Medytox Inc., and others.
Botulinum Toxin Market Scope
×
Get a free sample of
Botulinum Toxin Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below